As macrophages and T cells are the primary immune cells and major contributors to the TME of pancreatic cancer, other CD45+ immune cells were excluded from tumor organoids on purpose for a standardized and reproducible protocol (Figure 2F). The gene discussed is PTPRC; the disease is pancreatic neoplasm.